SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oscient Pharmaceuticals Corp. (OSCI)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
1154 42 0 GENE
Emcee:  Tara Cobble Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1079VC partner becomes chairman... Oscient Pharmaceuticals Announces Transition of Ian@SI-7/20/2005
1078Hey, this is a nice boost-----now need some more recommendations. mjMJ-6/14/2005
1077OSCI +7% (started with a Strong Buy at Roth; tgt $4)Ian@SI-6/14/2005
1076CAP is actually bigger than sinus (something I was confused about). The FDA is Biomaven-6/9/2005
1075Recent insider buy by CFO: finance.yahoo.com Cheers, Tucktuck-6/7/2005
1074Thanks, Ian! Rickscaram(o)uche-6/7/2005
1073Thanks. eomfred hayes-6/7/2005
1072He's talking at Pacific Growth Equities 2005 Life Sciences Conf. Yes it wilIan@SI-6/6/2005
1071Thanks. >He will talk to that slide in a couple minutes< Seems like I'fred hayes-6/6/2005
1070Filing accepted in Europe; discussing sNDA with FDA now (He will talk to that slIan@SI-6/6/2005
1069Nigel: Factive for pneumonia: Thanks for the post. Does anyone remember the statfred hayes-6/6/2005
1068Oscient Pharmaceuticals Achieves Primary Endpoint in Phase III Trial of FACTIVE nigel bates-6/6/2005
1067<My average price, I hate to admit, is 2.72. I do have a problem with low priExtra Pale-5/21/2005
1066I'm not even hinting that this is the turn (we've had similar days) but tom pope-5/20/2005
1065tuck, regarding partners, osci in JPM cc claims to have identified 40 partners:Extra Pale-5/12/2005
1064CC notes Factive partner needs: a) 400 more sales people; 5 year commitment. Ctuck-5/12/2005
1063I certainly have no facts that would lead me to disagree with your caution. I owtom pope-5/8/2005
1062OSCI is on my radar screen however it looks risky to me at this time. I like invgeorgiabiotech-5/8/2005
1061I listened to the latest CC today. Also on the call was the CEO for Auxilium. tuck-5/8/2005
1060The Yahoo MB on OSCI has a summary of one poster's view of OSCI. It gives OStom pope-5/8/2005
1059Revenues towards high end of range, but earnings are a miss. Launch expenses hituck-5/2/2005
1058I second that!Fizz-4/27/2005
1057Can use all the help we can get on this one. Thanks for news. mjMJ-4/27/2005
1056Oscient Pharmaceuticals OSCI started by Harris Nesbitt at Outperform Target: $6.Ian@SI-4/26/2005
1055Doubt if this is the often projected 'co-promotion' deal, since it does Extra Pale-4/13/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News